Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.

Open Angle Glaucoma (OAG) Clinical Trials

6 recruiting trials for Open Angle Glaucoma (OAG). Eligibility criteria explained in plain English.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
6
Total Trials
6
Recruiting Now
0
Phase 3 Trials
6
Sponsors

Recruiting Trials

RECRUITINGPhase 1NCT07290244

Evaluating ER-100 for Safety in People With Glaucoma or Non-Arteritic Anterior Ischemic Optic Neuropathy (Optic Nerve...

The goal of this clinical trial is to evaluate the safety and tolerability of a single dose of ER-100 in adults with optic nerve conditions, specifically Open Angle Glaucoma (OAG)...

Sponsor: Life Biosciences Inc.Enrolling: 182 locations
RECRUITINGNCT07325552

iStent Inject Versus Goniotomy With Kahook Dual Blade in Glauocma Treatment

The purpose of the study is to investigate the efficacy of cataract surgery in combination with Kahook Dual Blade Glide goniotomy (KDB) or iStent Inject W Trabecular Microbypass...

Sponsor: Medical University of BialystokEnrolling: 1002 locations
RECRUITINGNCT06691555

Long-term Safety and Efficacy of a Modified Suprachoroidal Silicone Tube (SST) Shunt

The goal of this observational study is to evaluate the long-term safety and efficacy of a modified suprachoroidal silicone tube (SST) shunt in treating patients with primary...

Sponsor: Davinci LTDEnrolling: 661 location
RECRUITINGNCT06865235

Efficacy and Safety of Gonioscopy Assisted Transluminal Trabeculotomy in Patients with Primary Open-angle Glaucoma and...

Prospective, randomized, , double-blind, clinical trial, comparing the variation of intraocular pressure (IOP) of patients with mild or moderate primary open-angle glaucoma (OAG)...

Sponsor: Faculdade de Ciências Médicas de Minas GeraisEnrolling: 901 location
RECRUITINGNCT06933836

DSLT Performance in Treatment-naïve Patients With Newly Diagnosed Open Angle Glaucoma

DSLT demonstrates a ≥ 20% reduction of IOP from pre-treatment baseline in POAG patients naïve of previous glaucoma treatment at 12 months.

Sponsor: Barnet Dulaney Perkins Eye CentersEnrolling: 551 location
RECRUITINGPhase 2NCT07354477

Single-site Pilot Study Evaluating the Effect of QLS-111 Ophthalmic Solution on Posterior Perfusion and Vessel Dilation

Pilot, single-site, prospective study of QLS-111 0.015 % in subjects with NPDR, OAG or NTG

Sponsor: Qlaris Bio, Inc.Enrolling: 141 location